Unknown

Dataset Information

0

Peptidoglycan Recognition Protein 4 Suppresses Early Inflammatory Responses to Bordetella pertussis and Contributes to Sphingosine-1-Phosphate Receptor Agonist-Mediated Disease Attenuation.


ABSTRACT: Incidence of whooping cough (pertussis), a bacterial infection of the respiratory tract caused by the bacterium Bordetella pertussis, has reached levels not seen since the 1950s. Antibiotics fail to improve the course of disease unless administered early in infection. Therefore, there is an urgent need for the development of antipertussis therapeutics. Sphingosine-1-phosphate receptor (S1PR) agonists have been shown to reduce pulmonary inflammation during Bordetella pertussis infection in mouse models. However, the mechanisms by which S1PR agonists attenuate pertussis disease are unknown. We report the results of a transcriptome sequencing study examining pulmonary transcriptional responses in B. pertussis-infected mice treated with S1PR agonist AAL-R or vehicle control. This study identified peptidoglycan recognition protein 4 (PGLYRP4) as one of the most highly upregulated genes in the lungs of infected mice following S1PR agonism. PGLYRP4, a secreted, innate mediator of host defenses, was found to limit early inflammatory pathology in knockout mouse studies. Further, S1PR agonist AAL-R failed to attenuate pertussis disease in PGLYRP4 knockout (KO) mice. B. pertussis virulence factor tracheal cytotoxin (TCT), a secreted peptidoglycan breakdown product, induces host tissue damage. TCT-oversecreting strains were found to drive an early inflammatory response similar to that observed in PGLYRP4 KO mice. Further, TCT-oversecreting strains induced significantly greater pathology in PGLYRP4-deficient animals than their wild-type counterparts. Together, these data indicate that S1PR agonist-mediated protection against pertussis disease is PGLYRP4 dependent. Our data suggest PGLYRP4 functions, in part, by preventing TCT-induced airway damage.

SUBMITTER: Skerry C 

PROVIDER: S-EPMC6346131 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Peptidoglycan Recognition Protein 4 Suppresses Early Inflammatory Responses to <i>Bordetella pertussis</i> and Contributes to Sphingosine-1-Phosphate Receptor Agonist-Mediated Disease Attenuation.

Skerry Ciaran C   Goldman William E WE   Carbonetti Nicholas H NH  

Infection and immunity 20190124 2


Incidence of whooping cough (pertussis), a bacterial infection of the respiratory tract caused by the bacterium <i>Bordetella pertussis</i>, has reached levels not seen since the 1950s. Antibiotics fail to improve the course of disease unless administered early in infection. Therefore, there is an urgent need for the development of antipertussis therapeutics. Sphingosine-1-phosphate receptor (S1PR) agonists have been shown to reduce pulmonary inflammation during <i>Bordetella pertussis</i> infec  ...[more]

Similar Datasets

| S-EPMC3786410 | biostudies-literature
| S-EPMC2413001 | biostudies-literature
| S-EPMC5466536 | biostudies-literature
| S-EPMC5748498 | biostudies-literature
| S-EPMC4734536 | biostudies-literature
2020-10-27 | GSE145049 | GEO
| S-EPMC8445185 | biostudies-literature
2020-05-01 | GSE137180 | GEO
2020-05-01 | GSE137027 | GEO
2016-08-20 | GSE77754 | GEO